SUMOylation Inhibition Enhances Dexamethasone Sensitivity in Multiple Myeloma
Li Du(City Of Hope National Medical Center), Steven T. Rosen(City of Hope)
Cited by 7
Related Papers
Role of SUMO activating enzyme in cancer stem cell maintenance and self-renewal
|Nature Communications|2016|132
Enzastaurin (LY317615), a protein kinase Cβ inhibitor, inhibits the AKT pathway and induces apoptosis in multiple myeloma cell lines
|Molecular Cancer Therapeutics|2006|81
Targeting the metabolic vulnerability of acute myeloid leukemia blasts with a combination of venetoclax and 8-chloro-adenosine
|Journal of Hematology & Oncology|2021|66
SUMOylation inhibition enhances dexamethasone sensitivity in multiple myeloma
|Journal of Experimental & Clinical Cancer Research|2022|55
Targeting Glucose Consumption and Autophagy in Myeloma with the Novel Nucleoside Analogue 8-Aminoadenosine
|Journal of Biological Chemistry|2009|44